Seeking Alpha We also have partnerships with Laureate Pharmaceuticals for the contract manufacture of our next generation enzyme replacement therapy in Pompe disease as well as a Japanese based company, JCR Pharmaceuticals, which we are partnered through our ... and more »
Seeking Alpha We've completed the GLP talks confirming a very broad therapeutic index with no liver enzyme elevations, no injection reactions for example. In fact, we went up to 300 mg/kg with an efficacy we've seen around 2.5 mg/kg without any ... There is ...
Seeking Alpha ... about $10 billion of revenue from products introduced within the past four years and these have been generated across the full range of our portfolio it includes a new fungicides for disease control in production agriculture, it includes a new ... and more »
